It’s TIME for a biomarker-driven approach to cancer immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 27,814 followers.

RT @sitcancer: August #JITC Commentary: It’s TIME for a biomarker-driven approach to cancer #immunotherapy https://t.co/qOJ6w9DZuN #Biomark…

RT @sitcancer: August #JITC Commentary: It’s TIME for a biomarker-driven approach to cancer #immunotherapy https://t.co/qOJ6w9DZuN #Biomark…

RT @sitcancer: August #JITC Commentary: It’s TIME for a biomarker-driven approach to cancer #immunotherapy https://t.co/qOJ6w9DZuN #Biomark…

RT @sitcancer: August #JITC Commentary: It’s TIME for a biomarker-driven approach to cancer #immunotherapy https://t.co/qOJ6w9DZuN #Biomark…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.